Results 41 to 50 of about 46,091 (305)

Disparities between IgG4-related kidney disease and extrarenal IgG4-related disease in a case–control study based on 450 patients

open access: yesScientific Reports, 2021
We aimed to compare the demographic, clinical and laboratory characteristics between IgG4-related kidney disease (IgG4-RKD+) and extrarenal IgG4-related disease (IgG4-RKD−) in a large Chinese cohort, as well as describing the radiological and ...
Qiaozhu Zeng   +11 more
doaj   +1 more source

Случай изолированного IgG4-связанного заболевания легких у подростка

open access: yes, 2020
IgG4-related disease (IgG4-RD) is a rare immune-mediated fibroinflammatory disease that is characterized by the occurrence of nodules in one or more organs and proceeds in most patients with the elevated levels of IgG4 in serum and/or in the tissues of ...
V. I. Vasilyev   +5 more
core   +1 more source

THU0588 CLINICAL PHENOTYPES OF IGG4-RELATED DISEASE IN SPAIN

open access: yes, 2019
Background: Recently, several clinical phenotypes in IgG4-related disease have been described in a multinational and ethnically variate cohort1. Objectives: To assess the clinical presentation of IgG4-related disease (IgG4-RD) in Spanish patients and ...
Iago Carballo   +15 more
core   +1 more source

Autoimmune Encephalitis in Acute Care—Pathology, Diagnosis, and Management

open access: yesAdvanced Science, EarlyView.
ABSTRACT Autoimmune encephalitis (AE) is characterized by immune‐mediated inflammation of the brain parenchyma, presenting with various neurological syndromes, including but not limited to seizures, altered consciousness, neuropsychiatric symptoms, and movement disorders.
Suneesh Thilak   +9 more
wiley   +1 more source

Epitope‐Resolved Digital SERS Profiling of Structurally Dynamic Antigens via a Multi‐Epitope Bispecific Antibody Framework

open access: yesAdvanced Science, EarlyView.
A multi‐epitope digital surface‐enhanced Raman spectroscopy framework enables epitope‐resolved immunoprofiling by integrating bispecific antibody fragments with spectrally encoded nanotags. This approach decouples binding events into independent digital channels, allowing structure‐aware antigen analysis.
Jing Wang   +4 more
wiley   +1 more source

Clinical and morphological characteristics of type 1 and 2 autoimmune pancreatitis

open access: yesAlʹmanah Kliničeskoj Mediciny, 2018
Rationale: In the recent years, an increased interest to autoimmune pancreatitis (AIP) has been seen, related to growing diagnostic potential. In its turn, this leads to an increase in numbers of diagnosed AIP cases.
S. V. Lishchuk   +3 more
doaj   +1 more source

Nanomaterials for Allergy Diagnosis and Treatment: Advances, Opportunities and Translational Challenges

open access: yesAdvanced Science, EarlyView.
Nanomaterials offer dual applications in allergy management. For diagnosis, nanomaterials enhance analytical sensitivity and improve detection in specific IgE and functional assays such as the basophil activation test (BAT). For allergen‐specific immunotherapy, nanomaterials enable allergen masking and controlled release, and effectively modulate the ...
Madiha Habib   +8 more
wiley   +1 more source

Hypereosinophilic syndrome with elevated IgG4 and T-cell clonality: A report of two cases

open access: yesOpen Life Sciences
In some cases, higher IgG4 levels are accompanied by increased circulating IgE, higher eosinophil counts, and various autoantibodies. Among these cases, IgG4-related disease (IgG4-RD) is one of the most frequently diagnosed conditions.
Huang Meichun   +3 more
doaj   +1 more source

Tolosa–Hunt Syndrome and IgG4 diseases in Neuro-Ophthalmology

open access: yesAnnals of Indian Academy of Neurology, 2022
Tolosa–Hunt syndrome (THS) remains a challenging diagnosis for many neurologists. Often believed to be a rare presentation, the classical presentation is known to involve cranial nerves and tissues surrounding the cavernous sinus.
Aastha Takkar Kapila   +2 more
doaj   +1 more source

Integrated Clinical and Proteomic Profiling of CD19 Chimeric Antigen Receptor T Cell Therapy in Progressive Systemic Sclerosis

open access: yesArthritis &Rheumatology, EarlyView.
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T cell therapy in patients with progressive systemic sclerosis (SSc). Methods Patients with progressive SSc received CD19 chimeric antigen receptor (CAR)‐T cell therapy and were observed longitudinally for safety, clinical efficacy,
Chenhan Jia   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy